Broadly neutralizing antibodies, or bnAbs, are a long‑standing goal of HIV vaccine research because they can disable many strains of the virus at once.

More than 30 million people with HIV must take antiretroviral therapy (ART) medications daily to keep the virus under control ...

One of the biggest hurdles in developing an HIV vaccine is coaxing the body to produce the right kind of immune cells and ...

More than 30 million people with HIV must take antiretroviral therapy (ART) medications daily to keep the virus under control, according to the Joint United Nations Programme on HIV/AIDS (UNAIDS). The ...

Switching to a long-acting cabotegravir/rilpivirine antiretroviral regimen may be safe for patients with HIV who have prior hepatitis B virus exposure, a real-world study shows.

Scientists at The Wistar Institute have developed an HIV vaccine candidate that achieves something never before observed in ...

Ferns, defined by large genomes, high chromosome counts, and pervasive aneuploidy as well as intraspecific polyploid ...

For more than a decade, doctors and researchers have announced that a handful of people around the world have been cured of ...

An Anglo-American team of researchers has devised a new computational method for quantifying Epstein-Barr virus (EBV) ...

By simplifying the engineering process and expanding what can be built, the Golden Gate method greatly broadens the possibilities for scientists working to develop bacteriophages as tools to combat ...

Brain cells that promote tumor expansion for aggressive cancers such as glioblastoma can be “flipped” to instead inhibit that ...

The emerging market for COVID-19 diagnostics offers significant opportunities, especially in home and office testing solutions and adapting lab capacities post-pandemic. Innovators in saliva tests, ...